Analyst initiations: DNA, HBC, STP, SPWR and FRPT
Posted Sep 21st 2007 11:00AM by Eric Buscemi
Filed under: Analyst reports, Genentech Inc (DNA), Analyst initiations, Suntech Power Hldgs ADS (STP), Savient Pharmaceuticals (SVNT)
.gif)
MOST NOTEWORTHY: Genentech, HSBC Holdings, Suntech Power, SunPower and Force Protection were today's noteworthy initiations:
- UBS is positive on Genentech Inc's (NYSE: DNA) leading industry franchises and potential upside from development projects and started shares with a Buy rating and $101 target.
- HSBC Holdings (NYSE: HBC) was assumed with a Reduce rating at WestLB, as the firm believes subprime concerns may hold back shares in the near-term.
- Jefferies initiated shares of SunTech Power Holdings (NYSE: STP) with a Buy rating and $45 target. The firm believes the company is positioned to beat 2007 and 2008 expectations by ramping manufacturing capacity and production faster than expected.
- Jefferies also resumed coverage of SunPower Corporation (NASDAQ: SPWR) with a Hold rating and $90 target, citing valuation, but believes the stock's higher multiple is justified given the company's superior growth potential.
- Force Protection Inc (NASDAQ: FRPT) was initiated with a Market Perform rating and Friedman Billings, as they believe near-term production expectations are too high given emerging DOD funding issues.
OTHER INITIATIONS:
Tags: analyst, arcelor mittal, ArcelorMittal, dna, firm, force protection, ForceProtection, frpt, genentech, hbc, heartland, hpy, hsbc, initiation, rf micro devices, rfmd, RfMicroDevices, savient, spwr, stp, sunpower, suntech, svnt
Related Posts
John McCain, losing ground, goes for broke tonight
If nothing else, gasoline prices are falling!
Closing Bell: Dow slump puts bulls on suicide watch; BAC, MS, F, FSLR all down, AMD up
